应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ABVX Abivax S.A.
交易中 09-18 13:06:42 EDT
11.55
+0.20
+1.76%
最高
11.61
最低
11.42
成交量
1.07万
今开
11.47
昨收
11.35
日振幅
1.67%
总市值
7.31亿
流通市值
3.04亿
总股本
6,327万
成交额
12.30万
换手率
0.04%
流通股本
2,628万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Abivax(ABVX.US)获Guggenheim首次覆盖,给予买入评级, 目标价50.00美元。
智通财经 · 04-29
Abivax(ABVX.US)获Guggenheim首次覆盖,给予买入评级, 目标价50.00美元。
Abivax(ABVX.US)获Piper Sandler首次覆盖,给予增持评级, 目标价42.00美元。
智通财经 · 04-29
Abivax(ABVX.US)获Piper Sandler首次覆盖,给予增持评级, 目标价42.00美元。
加载更多
公司概况
公司名称:
Abivax S.A.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Abivax Sa是一家于2013年12月4日根据法国法律注册成立。该公司是一家临床阶段的生物技术公司,专注于开发利用人体自然调节机制来调节慢性炎症性疾病患者免疫反应的疗法。该公司目前正在3期临床试验中评估主要候选药物奥贝法兹莫德,用于治疗成人中度至重度活动性溃疡性结肠炎。
发行价格:
--
{"stockData":{"symbol":"ABVX","market":"US","secType":"STK","nameCN":"Abivax S.A.","latestPrice":11.55,"timestamp":1726678861660,"preClose":11.35,"halted":0,"volume":10688,"delay":0,"floatShares":26282751,"shares":63265769,"eps":-3.791917,"marketStatus":"交易中","marketStatusCode":2,"change":0.2,"latestTime":"09-18 13:06:42 EDT","open":11.47,"high":11.61,"low":11.42,"amount":122985.26624,"amplitude":0.01674,"askPrice":11.61,"askSize":500,"bidPrice":11.46,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.791917,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1726689600000},"adr":0,"listingDate":1697774400000,"adjPreClose":11.35,"adrRate":1,"preHourTrading":{"tag":"盘前","latestPrice":10.86,"preClose":11.35,"latestTime":"05:22 EDT","volume":16,"amount":181.900016,"timestamp":1726651363536},"postHourTrading":{"tag":"盘后","latestPrice":11.35,"preClose":11.35,"latestTime":"16:00 EDT","volume":762,"amount":8648.699999999999,"timestamp":1726603201501},"volumeRatio":0.354238},"requestUrl":"/m/hq/s/ABVX","defaultTab":"news","newsList":[{"id":"2431835068","title":"Abivax(ABVX.US)获Guggenheim首次覆盖,给予买入评级, 目标价50.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2431835068","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2431835068?lang=zh_cn&edition=full","pubTime":"2024-04-29 18:21","pubTimestamp":1714386110,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2431882149","title":"Abivax(ABVX.US)获Piper Sandler首次覆盖,给予增持评级, 目标价42.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2431882149","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2431882149?lang=zh_cn&edition=full","pubTime":"2024-04-29 17:39","pubTimestamp":1714383545,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ABVX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abivax.com","stockEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":0.0461},{"period":"3month","weight":-0.1479},{"period":"6month","weight":-0.2316},{"period":"1year","weight":-0.0216},{"period":"ytd","weight":0.0607}],"compareEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":0.0158},{"period":"3month","weight":0.0266},{"period":"6month","weight":0.0783},{"period":"1year","weight":0.2692},{"period":"ytd","weight":0.1846}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Abivax Sa是一家于2013年12月4日根据法国法律注册成立。该公司是一家临床阶段的生物技术公司,专注于开发利用人体自然调节机制来调节慢性炎症性疾病患者免疫反应的疗法。该公司目前正在3期临床试验中评估主要候选药物奥贝法兹莫德,用于治疗成人中度至重度活动性溃疡性结肠炎。","exchange":"NASDAQ","name":"Abivax S.A.","nameEN":"Abivax S.A."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Abivax S.A.(ABVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Abivax S.A.(ABVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Abivax S.A.,ABVX,Abivax S.A.股票,Abivax S.A.股票老虎,Abivax S.A.股票老虎国际,Abivax S.A.行情,Abivax S.A.股票行情,Abivax S.A.股价,Abivax S.A.股市,Abivax S.A.股票价格,Abivax S.A.股票交易,Abivax S.A.股票购买,Abivax S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Abivax S.A.(ABVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Abivax S.A.(ABVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}